Table 2. Summary of the papers included in the review.
| First name | Years | Study type | Patients (n) | Ureter (n) | Mean age (years) | Mean follow-up length (months) | Mean total OT unilateral (min) | Mean total OT bilateral (min) | LOS (days) | Intra-op complication rate (%) | Success rate (patient) (%) | Success rate (ureter) (%) | Failure rate (patient) (%) | Failure rate (ureter) (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esposito (13) | 2019 | Retrospective comparative study | 35 | 51 | 7.5 | NA | 159.5 | 202 | 2.6 | 0 | 100 | NA | 0 | NA |
| Kawal (19) | 2018 | Retrospective cohort study | 128 | 179 | 4 | NA | NA | NA | NA | 0 | 100 | NA | 0 | NA |
| Boysen (30) | 2018 | Prospective cohort study | 143 | 199 | 6.6 | 7.4 | 159 | 195 | 1.5 | 0 | 91.4 | 93.8 | NA | 2 |
| Srinivasan (21) | 2017 | Retrospective cohort study | 92 | 127 | 3.8 | 14 | 150 | 178 | 1.4 | 0 | 91.3 | NA | NA | 2 |
| Boysen (20) | 2017 | Retrospective cohort study | 260 | 363 | 6.4 | NA | 152 | 198 | 1.6 | 0 | 84.9 | 87.9 | NA | 3.6 |
| Esposito (12) | 2018 | Retrospective cohort study | 55 | 55 | 4.9 | 28 | 92.2 | NA | 2 | 0 | 96.3 | NA | 1.8 | NA |
| Herz (22) | 2016 | Retrospective cohort study | 54 | 72 | 5.2 | NA | NA | NA | 1.8 | 0 | 84.7 | 85.2 | 14.8 | 15.3 |
| Arlen (14) | 2016 | Retrospective comparative study | 17 | 20 | 9.3 | 16.6 | 169.3 | NA | 1 | 0 | 88.2 | NA | 0 | NA |
| Gundeti (23) | 2016 | Retrospective cohort study | 58 | 83 | 5.3 | 30 | NA | NA | NA | 0 | NA | 82 | NA | 18 |
| Silay (24) | 2015 | Retrospective cohort study | 89 | 114 | 5.4 | NA | NA | NA | NA | 0 | NA | 97.9 | 0 | NA |
| Hayashi (15) | 2014 | Retrospective comparative study | 9 | 15 | 10 | NA | 144 | 211.5 | 7.4 | 11.1 | NA | 93.3 | 0 | NA |
| Dangle (1) | 2014 | Retrospective cohort study | 29 | 40 | 5.4 | NA | NA | NA | 1.8 | 0 | NA | 80 | NA | 2.5 |
| Schomburg (16) | 2014 | Retrospective comparative study | 20 | 25 | 6.2 | 39 | 165 | 227 | 1 | 0 | 100 | NA | 0 | NA |
| Grimsby (25) | 2015 | Retrospective cohort study | 61 | 93 | 6.7 | 11.7 | NA | NA | NA | 2 | 72 | NA | 28 | NA |
| Akhavan (26) | 2014 | Retrospective cohort study | 50 | 78 | 6.2 | 9.5 | NA | NA | 2 | 0 | NA | 92.3 | NA | 7.7 |
| Callewaert (27) | 2012 | Retrospective cohort study | 5 | 10 | 6.8 | 28 | NA | 162 | 2 | 20 | NA | 90 | 0 | NA |
| Chalmers (28) | 2012 | Retrospective cohort study | 17 | 23 | 6.2 | NA | 237 | 285 | 1.3 | 0 | 87.5 | 90.9 | 5.8 | NA |
| Kasturi (31) | 2012 | Prospective cohort study | 150 | 300 | 3.5 | NA | NA | 108 | 0.9 | 0 | 99.3 | NA | 0.7 | NA |
| Marchini (17) | 2011 | Retrospective comparative study | 20 | 30 | 8.6 | 12 | 209 | 233.5 | 1.7 | 0 | NA | 100 | 5 | NA |
| Smith (18) | 2011 | Retrospective comparative study | 25 | 33 | 5.7 | 16 | 177 | 203 | 1.4 | 0 | 96 | 97 | 8 | NA |
| Lee (29) | 2010 | Retrospective cohort study | 4 | 4 | 2.3 | 33 | 291 | NA | 2.3 | 0 | 100 | NA | 0 | NA |
OT, operative time; LOS, length of hospital stay; NA, not available.